ChinaAnticoagulantAPISuppliers [Name] Generic Name: Enoxaparin Sodium Injection 鈼?The only LWMH is recommended by ACC, ESC and CSC to cure UA and NSTEMI. 鈼?The only LWMH is approved to cure STEMI. 鈼?The only enoxaparin sodium which complies with EP 8.0 standard, and has EU and USA process patent in China. 鈼?Consistent with structure characteristics t of original drug Lovenox/Clexane, compare with other generic drugs, YINUOJIA has highest biologically equivalent and specific value of anti-FXa/anti-FIIa activity. At low risk of bleeding and high safety. 鈼?Obtained the special project support of new medicine development form the state council, and excellence award of state patent for invention, Class B drugs of National medical insurance, Basic drugs in some provinces and cities. [Indication] 1. Prevention of venous thromboembolic diseases, especially thrombosis associated with orthopedic or general surgery. 2. Treatment of established deep venous thromboembolic with or without pulmonary embolism. 3. Prevention of thrombus formation in the extra-corporal circulation during hemodialysis. 4. Treatment of acute unstable angina and non-Q-wave myocardial infraction, administered concurrently with aspirin. Treatment of acute ST-segment elevation myocardial infarction with thrombolytics or combined with percutaneous coronary intervention (PCI). Covering all provinces and cities horizontally, and covering prefectures vertically. Over the past five years, the coverage of provinces has expanded from 11 provinces in 2014 to 29 provinces (except Tibet, Hong Kong, Macao and Taiwan) Manufacturing and Quality Adhere to the concept of "quality from design", quality standards are far higher than the external requirements. Strictly comply with the new GMP requirements, take reference from the EU GMP and US FDA standards to design production workshop. Introduce foreign advanced equipment for key processes. The production line of JILIFEN formulated bulk has passed the EU GMP certification. Company Honor National New High-tech Enterprise Key New High-tech Enterprise of National Torch Plan National superior enterprise of intellectual property Provincial New High-tech Research & Development Center Zhejiang Jiuyuan Gene Engineering Biopharmaceutical Research Institute Zhejiang province per mu benefit leading enterprises Gene-engineering New Drug R&D Technology and Service Sub-platform Provincial Post-doctoral Scientific Research Working CenterChinaAnticoagulantAPISuppliers website:http://www.jiuyuangene.net/ap/anticoagulant-api/